StockData
Xtant Medical Holdings, Inc. logo

Xtant Medical Holdings, Inc. (XTNT) stock

XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 9/3074% below fair value
$0.28−0.00 (-0.94%)

Close on Nov 12, 2026Market cap $38.62MP/E –Yield –

Xtant Medical total assets

Total assets on the balance sheet at the end of each period.

Xtant Medical's total assets was $79.67M at Jun 30, 2026. For fiscal 2025 it was $94.15M, up 0.3% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $144.10M in fiscal 2016.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$94.15M+0.3%
FY2024Dec 31, 2024$93.84M+1.3%
FY2023Dec 31, 2023$92.61M+53.8%
FY2022Dec 31, 2022$60.23M+10.1%
FY2021Dec 31, 2021$54.69M+31.9%
FY2020Dec 31, 2020$41.47M-3.9%
FY2019Dec 31, 2019$43.16M-7.0%
FY2018Dec 31, 2018$46.42M-56.1%
FY2017Dec 31, 2017$105.71M-26.6%
FY2016Dec 31, 2016$144.10M+2.2%
FY2015Dec 31, 2015$141.03M+404.6%
FY2014Dec 31, 2014$27.95M-3.2%
FY2013Dec 31, 2013$28.88M-16.3%
FY2012Dec 31, 2012$34.50M+48.9%
FY2011Dec 31, 2011$23.17M+47.0%
FY2010Dec 31, 2010$15.76M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$79.67M-23.0%
Q1 FY2026Mar 31, 2026$78.00M-18.6%
Q4 FY2025Dec 31, 2025$94.15M+0.3%
Q3 FY2025Sep 30, 2025$106.32M+7.5%
Q2 FY2025Jun 30, 2025$103.48M+8.3%
Q1 FY2025Mar 31, 2025$95.83M+2.0%
Q4 FY2024Dec 31, 2024$93.84M+1.3%
Q3 FY2024Sep 30, 2024$98.88M+7.5%
Q2 FY2024Jun 30, 2024$95.58M+46.6%
Q1 FY2024Mar 31, 2024$93.93M+48.4%
Q4 FY2023Dec 31, 2023$92.61M+53.8%
Q3 FY2023Sep 30, 2023$92.00M+64.1%
Q2 FY2023Jun 30, 2023$65.22M+23.7%
Q1 FY2023Mar 31, 2023$63.32M+19.1%
Q4 FY2022Dec 31, 2022$60.23M+10.1%
Q3 FY2022Sep 30, 2022$56.05M+0.5%
Q2 FY2022Jun 30, 2022$52.71M-11.7%
Q1 FY2022Mar 31, 2022$53.17M-9.4%
Q4 FY2021Dec 31, 2021$54.69M+31.9%
Q3 FY2021Sep 30, 2021$55.79M+31.6%
Q2 FY2021Jun 30, 2021$59.68M+43.2%
Q1 FY2021Mar 31, 2021$58.70M+37.9%
Q4 FY2020Dec 31, 2020$41.47M-3.9%
Q3 FY2020Sep 30, 2020$42.39M-1.5%
Q2 FY2020Jun 30, 2020$41.67M-6.4%
Q1 FY2020Mar 31, 2020$42.55M-9.6%
Q4 FY2019Dec 31, 2019$43.16M-7.0%
Q3 FY2019Sep 30, 2019$43.04M-56.6%
Q2 FY2019Jun 30, 2019$44.50M-56.7%
Q1 FY2019Mar 31, 2019$47.07M-55.1%
Q4 FY2018Dec 31, 2018$46.42M-56.1%
Q3 FY2018Sep 30, 2018$99.27M-22.7%
Q2 FY2018Jun 30, 2018$102.79M-23.1%
Q1 FY2018Mar 31, 2018$104.78M-24.7%
Q4 FY2017Dec 31, 2017$105.71M-26.6%
Q3 FY2017Sep 30, 2017$128.46M-9.8%
Q2 FY2017Jun 30, 2017$133.68M–
Q1 FY2017Mar 31, 2017$139.07M–
Q4 FY2016Dec 31, 2016$144.10M–
Q3 FY2016Sep 30, 2016$142.45M–

More Xtant Medical figures

See a number that looks wrong?